TGFB1 and systemic sclerosis: At variance with the Boyden chamber assay, the wound healing assay does not require only migration of cells but also proliferation, which may have been impaired by transforming growth factor-β (TGF-β) or other cytotoxic factors present in the serum of SSc patients.